AI assistant
Sending…
Chemours Co — Director's Dealing 2021
Dec 3, 2021
31561_dirs_2021-12-03_3534a3b4-f0cf-4d9b-9614-0f3aed7052d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2021-12-02
Reporting Person: Ralhan Sameer (SVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-02 | Common Stock | M | 17482 | $18.45 | Acquired | 316631.9063 | Direct |
| 2021-12-02 | Common Stock | S | 17482 | $29.85 | Disposed | 299149.9063 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-02 | Stock Option (Right to Buy) | $18.45 | M | 17482 | Disposed | 2022-02-03 | Common Stock (17482) | Direct |
Footnotes
F1: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
F2: Includes directly owned shares, restricted stock units, and dividend equivalent units.
F3: Shares were sold in multiple transactions at prices ranging from $29.55 to $30.08.
F4: Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.
More from Chemours Co
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3